breast cancer

This week's Addicted to Fitness focuses on the recent rise of cancer incidences. Nick and Shannon discuss the possible causes of the rise in cancer incidences, especially among young people, and how early screenings & lifestyle changes could help reduce your chances of developing cancer. Follow the podcast profile on Instagram @TheATFPodcast. Give it a listen and let us know what you think by leaving a rating & review in Apple Podcasts.

On this week’s podcast, Dr Louise is joined by Dr Peter Greenhouse, a menopause specialist with 40 years’ experience in women’s sexual healthcare who is actively involved in postgraduate lecturing.

He has recently spoken out about NICE’s draft menopause guideline update, and tells Dr Louise it contains inappropriate and inaccurate statements, particularly concerning HRT and breast cancer safety, and ignores the cardioprotective effect of HRT when it’s started within 10 years of the menopausal transition.

Dr Peter challenges NICE’s stance on HRT for primary prevention and proposes a pre-emptive approach that could help reduce the amount of other medications GPs are prescribing menopausal women.

Finally, he shares his belief that women should be able to take as much HRT for as long as they need to.

You can read about Newson Health’s response to the NICE draft guideline consultation here.

Follow Dr Peter Greenhouse on X @GreenhousePeter

You can read Roger Lobo's paper, Back to the Future, which is referred to in the podcast, here.

Click here for more on Newson Health

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

Harold (Hal) Burstein is an internationally renowned breast cancer expert. In this episode, Hal discusses a broad range of topics related to breast cancer, starting with the intricacies of breast anatomy and the endocrinological factors at play. He covers the spectrum of breast cancer, from precancerous lesions to invasive breast cancer, classifying these conditions into a helpful framework. He delves into various screening methods, including self-exams, mammograms, ultrasounds, and MRIs, and addresses the ongoing debate surrounding early screening and detection. Hal provides insights into the latest advancements in cancer treatment, offering valuable guidance for individuals to understand their unique circumstances within the three primary categories of breast cancer. Finally, Hal delves into the role of genetics in breast cancer and brings attention to the less commonly addressed issue of male breast cancer.

We discuss:

• The prevalence and mortality rate of breast cancer in women [4:15];
• The anatomy of the breast and the complex factors behind breast cancer development [6:30];
• The three main categories of breast cancer [16:45];
• Breast cancer risk: the impact of menopause, estrogen, breast density, obesity, and more [21:15];
• Finding and evaluating lumps in the breast [25:30];
• Identifying and treating precancerous lesions like ductal carcinoma in situ (DCIS) [31:00];
• Post-lumpectomy for DCIS: standard of care, future risk of cancer, and pros and cons of radiation and other preventative options [41:15];
• Lobular carcinoma in situ (LCIS): how it differs from DCIS in terms of treatment and future risk of invasive cancer [55:00];
• Breast cancer screening: mammography, ultrasound, MRI, and more [1:03:45];
• Invasive breast cancer: pathology report, surgery, and survival [1:11:00];
• The argument for aggressive screening for breast cancer [1:22:15];
• Advances in the treatment of breast cancer, adjuvant therapy, and neoadjuvant therapy [1:27:00];
• The use of hormone replacement therapy in women who are in remission from breast cancer [1:41:15];
• The role of genetics in breast cancer [1:44:45];
• The importance of multidisciplinary care delivered by cancer centers [1:53:15];
• Breast cancer in men [2:03:30];
• Parting thoughts and takeaways [2:05:45]; and
• More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

Hey podcast community, Dr. Mark here. My team and I are so excited to offer you a 7 Day Free trial of the Dr. Hyman+ subscription for Apple Podcast. For 7 days, you get access to all this and more entirely for free!  It's so easy to sign up. Just go click the Try Free button on the Doctor’s Farmacy Podcast page in Apple Podcast. 

In this teaser episode, you’ll hear a preview of our monthly Ask A Doctor Anything episode with Dr. Elizabeth Boham.

Want to hear the full episode? Subscribe now. With your 7 day free trial to Apple Podcast, you’ll gain access to audio versions of:

- Ad-Free Doctor’s Farmacy Podcast episodes

- Exclusive monthly Functional Medicine Deep Dives

- Monthly Ask Mark Anything Episodes 

- Bonus audio content exclusive to Dr. Hyman+

Trying to decide if the Dr. Hyman+ subscription for Apple Podcast is right for you?  Email my team at plus@drhyman.com with any questions you have.  

Please note, Dr. Hyman+ subscription for Apple Podcast does not include access to the Dr. Hyman+ site and only includes Dr. Hyman+ in audio content. 

Hosted on Acast. See acast.com/privacy for more information.

This week's Addicted to Fitness features an informative conversation with hematologist & oncologist Dr. Savan Shah. Nick and Dr. Shah discuss cancer types, symptoms, risk factors, screenings, and new methods that are personalizing cancer treatment. Visit uspreventiveservicestaskforce.org/uspstf/ for more information on cancer screenings. Follow the podcast profile on Instagram @TheATFPodcast. Give it a listen and let us know what you think by leaving a rating & review in Apple Podcasts.

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Sign Up to Receive Peter’s Weekly Newsletter

JoAnn Manson is a world-renowned endocrinologist, epidemiologist, and Principal Investigator for the Women’s Health Initiative (WHI). In this episode, she dives deep into the WHI to explain the study design, primary outcome, confounding factors, and nuanced benefits and risks of hormone replacement therapy (HRT). JoAnn reflects on how a misinterpretation of the results, combined with sensationalized headlines regarding an elevated risk of breast cancer, led to a significant shift in the perception and utilization of HRT. From there, they take a closer look at the breast cancer data to separate fact from fiction. Additionally, JoAnn gives her take on how one should weigh the risks and benefits of HRT and concludes with a discussion on how physicians can move towards better HRT practices.

We discuss:

• The Women’s Health Initiative: the original goal of the study, hormone formulations used, and potential confounders [4:15];
• Study design of the Women’s Health Initiative, primary outcome, and more [16:00];
• JoAnn’s personal hypothesis about the ability of hormone replacement therapy to reduce heart disease risk prior to the WHI [26:45];
• The relationship between estrogen and breast cancer [30:45];
• Why the WHI study was stopped early, and the dramatic change in the perception and use of HRT due to the alleged increase in breast cancer risk [37:30];
• What Peter finds most troubling about the mainstream view of HRT and a more nuanced look at the benefits and risks of HRT [45:15];
• HRT and bone health [56:00];
• The importance of timing when it comes to HRT, the best use cases, and advice on finding a clinician [59:30];
• A discussion on the potential impact of HRT on mortality and a thought experiment on a long-duration use of HRT [1:03:15];
• Moving toward better HRT practices, and the need for more studies [1:10:00]; and
• More.

Connect With Peter on Twitter, Instagram, Facebook and YouTube

Did you know that you can be perimenopausal or menopausal at any age? On this episode of The Liz Earle Wellbeing Show, Liz is joined by GP and menopause specialist Dr Louise Newson to learn more about the reasons why some women may experience non-typical onset menopause and early menopause.

Liz and Louise discuss two listeners’ questions on experiencing non-typical menopause onset due to breast cancer and Sheehan’s Syndrome, a rare condition involving injury to your pituitary gland during childbirth.

The episode delves into breast cancer and risk factors, the importance of joint decision making between doctor and patient, and the differences between HRT and contraception prescribing.

Links mentioned in the episode:

• Visit the Dr Louise Newson website
• Learn more about The Menopause Charity
• Find out more about The Balance app and website
• Purchase Dr Louise's book, The Definitive Guide to Perimenopause and Menopause
• Listen to Dr Louise's podcast
• Subscribe to Liz Earle Wellbeing Magazine

Hosted on Acast. See acast.com/privacy for more information.

Want to know more about HRT? On this episode of The Liz Earle Wellbeing Show, Liz is joined by Avrum Bluming, medical oncologist and author, to learn more about oestrogen and why it matters.

Liz and Avrum discuss the inequality of healthcare between men and women, plus what the data says about the importance of oestrogen for preventing osteoporosis and other health conditions.

They also cover breast cancer and oestrogen, the past misinterpretation of data, and answer commonly asked HRT and menopause questions.

Links mentioned in the episode:

• Purchase Oestrogen Matters here
• Listen to Everything You Need To Know About HRT And More, with Dr Rebecca Lewis here
• Listen to Breast Cancer, HRT And What The Evidence Says, with Kirsty Lang and Dr Sarah Glynne here
• Subscribe to Liz Earle Wellbeing Magazine

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

Donald Trump says allowing the emergency use of blood plasma therapy for coronavirus patients will save “countless lives” and is “proven to reduce mortality by 35%”. We look at the evidence. Amid talk of coronavirus being back on the rise in the UK, what does the data show? Could screening for breast cancer from the age of 40 save lives? And can it really be true than one in five women in 18th century London made a living selling sex?

Is HRT safe? Can we take HRT forever? Should women with no menopausal symptoms take HRT to protect their long term health? Consultant gynaecologist and Secretary General of the International Menopause Society Mr Nick Panay spills the beans on this all-important treatment. You can find all the resources and links mentioned in the episode at lizearlewellbeing.com/making-sense-of-hrt-nick-panay/.

This is the second instalment in our five part podcast special in celebration of World Menopause Day.

Hosted on Acast. See acast.com/privacy for more information.

Hosted on Acast. See acast.com/privacy for more information.

This is the second part of Liz's interview with renowned breast cancer surgeon, Professor Michael Baum. In the first episode we took a deep dive into breast cancer (its causes, types and treatments) and in this second segment Liz and Michael discuss breast health more widely including the surprising reality of breast cancer screening and ways to improve the quality of life, health and vitality of all mid-life women. 

You can find the show notes with all the resources and links mentioned in the episode at https://lizearlewellbeing.com/s4e7/.

Hosted on Acast. See acast.com/privacy for more information.

In this episode, Avrum Bluming, hematologist, medical oncologist, and emeritus clinical professor at USC and Carol Tavris, social psychologist and author of Mistakes Were Made (But Not By Me), discuss their collaboration on their recent book, Estrogen Matters. Their book takes on the very polarizing and confusing topic of hormone replacement therapy for women suffering with symptoms of menopause. In many ways, the story and history of HRT is in striking parallel to the bad science that led up to the dietary guidelines being set forth in 1980. Carol and Avrum make a compelling case that most women benefit greatly from being on postmenopausal hormone replacement therapy, and can do so without increasing their risk of breast cancer. We also cover the history of HRT, the impact of the Women's Health Initiative, and take a deep dive into each of the clinical conditions for which HRT should be considered, such as cardiovascular disease, neurodegenerative disease, and osteoporosis, to name a few.